Author | J. Douglas Rizzo, MD, MS | OncLive

Author | J. Douglas Rizzo, MD, MS


Dr. Rizzo on Impact of Age on Survival Outcomes in MDS After HCT

December 31, 2015


J. Douglas Rizzo, MD, MS, assistant scientific professor, Center for International Blood and Marrow Transplant Research, professor of Medicine, Medical College of Wisconsin, discusses a study that examined if age affects survival outcomes in patients with myelodysplastic syndromes who receive a hematopoietic cell transplant.